Cambridge Trust’s NeueHealth NEUE Stock Holding History

Cambridge Trust’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	–	–	1199
2021 Q4	$0	Buy	+1	New	+$462	﹤0.01%	1147

Other funds holding NEUE

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return

Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Cambridge Trust's NEUE Position: Q1 2022 in Review

Cambridge Trust sold out of NeueHealth (NEUE) in Q1 2022, closing a stake of 1 share.

Cambridge Trust first reported a position in NEUE in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 121 funds tracked by Wall St. Rank hold NEUE as of Q1 2022.

Cambridge Trust reported no remaining NeueHealth position as of Q1 2022 after selling out during the quarter.
Cambridge Trust sold 1 NeueHealth share in Q1 2022.
Cambridge Trust first reported a position in NeueHealth in Q4 2021 and held it in 1 quarter.
Cambridge Trust's NeueHealth position peaked at $0 in Q4 2021.
121 funds tracked by Wall St. Rank held NeueHealth as of Q1 2022.

Based on Cambridge Trust's 13F filing for Q1 2022, filed 12 May 2022.